中国肿瘤临床2024,Vol.51Issue(3) :133-137.DOI:10.12354/j.issn.1000-8179.2024.20231246

蛋白质糖基化修饰在结直肠癌中的研究进展

Research progress on protein glycosylation modification in colorectal cancer

刘晓凡 顾冬英
中国肿瘤临床2024,Vol.51Issue(3) :133-137.DOI:10.12354/j.issn.1000-8179.2024.20231246

蛋白质糖基化修饰在结直肠癌中的研究进展

Research progress on protein glycosylation modification in colorectal cancer

刘晓凡 1顾冬英1
扫码查看

作者信息

  • 1. 南京医科大学附属南京医院,南京市第一医院肿瘤科(南京市 210000)
  • 折叠

摘要

结直肠癌作为中国最常见的恶性肿瘤之一,涉及多种复杂的病理生理过程.随着糖组学的深入研究,揭露了蛋白质糖基化修饰与结直肠癌的发生、进展、转移及多药耐药的密切关系,糖基化的改变作为重要的生物标志物,为早期诊断及干预治疗提供了新的靶点.本文综述了蛋白质糖基化修饰在结直肠癌中最新研究进展,希望可以通过靶向相关糖基化修饰位点,改善患者预后及耐药性.

Abstract

Colorectal cancer,one of the most common cancer types in China,involves multiple complex pathophysiological processes.In-depth studies of glycomics,have revealed close relationships between alterations in protein glycosylation and the occurrence,progression,metastasis,and multidrug resistance of colorectal cancer.Changes in glycosylation can serve as important biomarkers and provide new as-says for early diagnosis and targets for intervention.This article reviews the latest research into altered protein glycosylation in colorectal cancer,with the goal of improving patient prognosis and reducing drug resistance by identifying relevant sites of altered glycosylation.

关键词

蛋白质翻译后修饰/糖基化/结直肠癌/多药耐药

Key words

post-translational modification on proteins/glycosylation/colorectal cancer/multidrug resistance

引用本文复制引用

基金项目

国家自然科学基金面上项目(82073631)

出版年

2024
中国肿瘤临床
中国抗癌协会

中国肿瘤临床

CSTPCD北大核心
影响因子:1.32
ISSN:1000-8179
参考文献量33
段落导航相关论文